Translating evidence into policy: Early lessons from the Bangladesh newborn vitamin A supplementation experience
In light of expanding global health research projects and worldwide progress toward Millennium Development Goals, understanding the process by which significant research findings become global and national health policy is critical. While there may be considerable interest, there is a dearth of research that examines this translational process in terms of health initiatives, much less in the context of a developing country. This project will use the newborn vitamin A supplementation (NVAS) trials in Bangladesh as a case study to examine this process. To understand the three-year delay between the efficacy reports of an approximate 20 percent reduction in infant mortality due to NVAS and the government policy to allow feasibility studies for the intervention, this study will investigate the events and stakeholders that played a role in promoting or impeding the policymaking process. We will use an existing framework for translative health research as model for this project, leading to our analysis of influential actors, ideas, political contexts, and issue characteristics through the categorization and scoring of an ?Events Log?, key informant interviews, and SWOT analysis workshops. This study will demonstrate how complex, disjointed, and laborious the path from research to policy can be, but it is our objective to develop a better understanding of this process, especially in a developing nation. In doing so, the project will serve as a guide for future researchers interested in having their research findings enacted as policies and programs for the communities who need them the most.